Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-κB and STAT3 pathways highlighting mechanisms of immune evasion and potential for combination therapy
Hirohito Naito(Kagawa University), Mikio Sugimoto(Kagawa University)
Cited by 2
Related Papers
Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer
|International Journal of Molecular Sciences|2022|18
Positive Culture Prior to Transperineal Prostate Biopsy Was Not Associated with Post-Biopsy Febrile Urinary Tract Infection Development
|Research and Reports in Urology|2021|11